| Company Name | Logo | Symbol | Rating ⓘ | Shares (M) | Final Price | Price Range | Underwriter(s) | Offer Amount | Expected |
|---|---|---|---|---|---|---|---|---|---|
|
TRex Bio, Inc.
|
|
TRXB | Unlock Rating for Free ⓘ | 8.33M | $14.00-$16.00 | J.P. Morgan, Evercore ISI, Cantor, Stifel, Wedbush | $125.00M | 10/9/2026 | |
|
Aggreko Inc.
|
|
AGKO | Unlock Rating for Free ⓘ | Goldman Sachs, J.P Morgan, BofA Securities, Morgan Stanley | $100.00M | Q4 2026 | |||
|
Anthropic PBC
|
|
ANTP | Unlock Rating for Free ⓘ | $100.00M | Q4 2026 | ||||
|
City Therapeutics Inc.
|
|
CTY | Unlock Rating for Free ⓘ | Goldman Sachs, Jefferies, Stifel, Oppenheimer | $100.00M | Q4 2026 | |||
|
CoVolt Power Inc.
|
|
KVLT | Unlock Rating for Free ⓘ | J.P. Morgan, Jefferies | $100.00M | Q4 2026 | |||
|
Cumberland Farms Ltd.
|
|
CMBY | Unlock Rating for Free ⓘ | BofA Securities, Goldman Sachs, Jefferies | $100.00M | Q4 2026 | |||
|
DayOne Data Centers Limited
|
|
DODC | Unlock Rating for Free ⓘ | Morgan Stanley, J.P. Morgan, BofA Securities, Citigroup | $100.00M | Q4 2026 | |||
|
Entrata, Inc.
|
|
ENT | Unlock Rating for Free ⓘ | Goldman Sachs, J.P. Morgan, Barclays | $100.00M | Q4 2026 | |||
|
Genneia S.A.
|
|
GENN | Unlock Rating for Free ⓘ | Morgan Stanley, BTG Pactual | $100.00M | Q4 2026 | |||
|
Iambic Therapeutics, Inc.
|
|
IAM | Unlock Rating for Free ⓘ | J.P. Morgan, Jefferies, BofA Securities, Citigroup | $100.00M | Q4 2026 | |||
|
Lycia Therapeutics Inc.
|
|
LYCA | Unlock Rating for Free ⓘ | Jefferies, TD Cowen, Evercore ISI, Guggenheim | $100.00M | Q4 2026 | |||
|
Nscale Limited
|
|
NSCL | Unlock Rating for Free ⓘ | Goldman Sachs, J.P. Morgan, Morgan Stanley | $100.00M | Q4 2026 | |||
|
SB Energy Inc.
|
|
SBE | Unlock Rating for Free ⓘ | J.P. Morgan, Goldman Sachs, Morgan Stanley, Citigroup, Mizuho | $100.00M | Q4 2026 | |||
|
Syntiant Corp.
|
|
SYTN | Unlock Rating for Free ⓘ | Citigroup, BofA Securities, UBS Investment Bank | $100.00M | Q4 2026 | |||
|
Tailored Brands, Inc.
|
|
MENW | Unlock Rating for Free ⓘ | Goldman Sachs, Morgan Stanley, Jefferies | $100.00M | Q4 2026 | |||
|
TFP Group Ltd.
|
|
TFP | Unlock Rating for Free ⓘ | Morgan Stanley, Barclays, J.P. Morgan | $100.00M | Q4 2026 | |||
|
The Wella Company
|
|
WELA | Unlock Rating for Free ⓘ | Goldman Sachs, BofA Securities, KKR, J.P. Morgan | $100.00M | Q4 2026 | |||
|
YPF Energía Eléctrica S.A.
|
|
YLUZ | Unlock Rating for Free ⓘ | Goldman Sachs, BofA Securities, Citigroup | $100.00M | Q4 2026 |
IPO Prophet® Heat Index
43
WARM
Current Regime
Real-time market sentiment and predictive analytics that give you the edge.
Unlock Heat Index Analytics for Free
30-day free trial. Cancel anytime.
On the Tape
IPO FILING ALERT
Company: Lycia Therapeutics Inc. Ticker: LYCA Expected Date: Q4 2026 Offer Amount: $100.00M Underwriters: Jefferies, TD …
Oct 5, 2026
IPO FILING ALERT
Company: DayOne Data Centers Limited Ticker: DODC Expected Date: Q4 2026 Offer Amount: $100.00M Underwriters: Morgan Sta…
Oct 5, 2026
IPO TERMS ALERT
Company: TRex Bio, Inc. Ticker: TRXB Price Range: $14.00-$16.00 Shares Offered: 8.33M shares Offer Amount: $125.00M Unde…
Oct 5, 2026
ACCV IPO OPEN FOR TRADING
Company: Accelevation Holdings Corp. Ticker: ACCV NOW TRADING Issue Price: $18.00 Opening Price: $17.55 Change: -2.50%
Sep 30, 2026
ACCV INDICATION TIME
The initial public offering of Accelevation Holdings Corp. (ACCV) will be released on Nasdaq today for quotation at 10:1…
Sep 30, 2026
IPO PRICING ALERT
Company: Accelevation Holdings Corp. Ticker: ACCV Price: $18.00 Shares: 30.00M shares Range: $20.00-$24.00 Underwriters:…
Sep 29, 2026
OURA IPO POSTPONED
Oura Postpones IPO Over Market Uncertainty on Tuesday September 29, 2026.
Sep 29, 2026
IPO FILING ALERT
Company: TFP Group Ltd. Ticker: TFP Expected Date: Q4 2026 Offer Amount: $100.00M Underwriters: Morgan Stanley, Barclays…
Sep 25, 2026